[
    "{\"step_by_step_thinking\": \"Erenumab is a monoclonal antibody that is used for the prevention of migraine headaches. It works by blocking the calcitonin gene-related peptide (CGRP) receptor, which is involved in the pathophysiology of migraines. Therefore, the answer is yes, erenumab does target the calcitonin gene-related peptide.\", \"answer_choice\": \"A\"}"
]